$4.73
-0.02 (-0.42%)
Open$4.75
Previous Close$4.75
Day High$4.80
Day Low$4.63
52W High$23.20
52W Low$3.51
Volume—
Avg Volume4.08M
Market Cap565.73M
P/E Ratio—
EPS$-1.95
SectorPharmaceuticals
Analyst Ratings
Hold
17 analysts
Price Target
+794.7% upside
Current
$4.73
$4.73
Target
$42.32
$42.32
$27.22
$42.32 avg
$56.32
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 107.60M | 98.41M | 180.40M |
| Net Income | -286,491,642 | -235,817,155 | 49.45M |
| Profit Margin | -266.3% | -252.9% | 27.4% |
| EBITDA | -287,459,795 | -249,759,287 | 94.91M |
| Free Cash Flow | — | — | 60.57M |
| Rev Growth | +9.3% | +9.3% | -1.4% |
| Debt/Equity | 0.20 | 0.20 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |